<html>
<head>PUBMED IDs for DNAJC13</head>
<body bgcolor='#C5F0F2'><h1>DNAJC13</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21520241/'>Exome sequencing of a pedigree with Tourette syndrome or chronic tic disorder.</a> June 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21520232/'>Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.</a> June 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22507240/'>Analysis of the MRPL3, DNAJC13 and OFCC1 variants in Chinese Han patients with TS-CTD.</a> September 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24126164/'>DNAJ mutations are rare in Chinese Parkinson's disease patients and controls.</a> September 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25393719/'>DNAJC13 genetic variants in parkinsonism.</a> October 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25550792/'>Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.</a> September 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25550792/'>Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.</a> September 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26278106/'>DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.</a> April 19  2015<br></body></html>
